Tailored steroid tapering could improve lupus care
NCT ID NCT03187743
First seen Mar 11, 2026 · Last updated Apr 28, 2026 · Updated 2 times
Summary
This study tested a personalized method for safely lowering steroid doses in people with lupus. Researchers monitored 72 patients over three months to see how their bodies processed the medication. The goal was to find the best way to reduce steroids while keeping the disease under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Necker Enfants Malades
Paris, Paris, 75015, France
Conditions
Explore the condition pages connected to this study.